Indo US Bio-Tech Ltd Q2 FY2024-2025 Results: Summary
Revenue | ₹22.19Cr |
Net Profits | ₹4.36Cr |
Net Profit Margins | 19.65% |
Highlights
Revenue:
Indo US Bio-Tech Ltd’s revenue jumped 40.27% since last year same period to ₹22.19Cr in the Q2 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -10.34% fall in its revenue since last 3-months.
Net Profits:
Indo US Bio-Tech Ltd’s net profit jumped 161.08% since last year same period to ₹4.36Cr in the Q2 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 37.54% jump in its net profits since last 3-months.
Net Profit Margins:
Indo US Bio-Tech Ltd’s net profit margin jumped 86.13% since last year same period to 19.65% in the Q2 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 53.41% jump in its net profit margins since last 3-months.
